Impact of Implementation of an Enhanced Recovery After Surgery Program in Laparoscopic Roux-en-Y Gastric Bypass
NCT ID: NCT03212573
Last Updated: 2017-07-11
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE3
180 participants
INTERVENTIONAL
2016-03-01
2017-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Postoperative pain 24 hours after surgery and hospital stay will be assessed.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Assessing the Safety and Performance of the easyEndoTM Universal Linear Cutting Stapler in Laparoscopic Gastric Bypass Surgery
NCT03968757
Vitamin E on Staple Line and Anastomoses of Roux-en-Y Gastric Bypass
NCT03765827
Roux-en-Y Gastric Bypass: Clinical Trial
NCT04649619
The Influence of Aerobic Endurance Training After Roux-en-Y-Gastric Bypass
NCT00875186
Gastric Bypass With Different Lengths of the Bilipancreatic Limb
NCT05334173
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Postoperative pain 24 hours after surgery, as measured by Visual Analogic Scale, and hospital stay will be assessed.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ERAS protocol
ERAS protocol includes early oral intake (6 hours after surgery), early deambulation (6h after surgery) and multimodal analgesia (port-sites infiltration with Bupivacain 0.5% combined with postoperative intravenous analgesia)
ERAS protocol
ERAS protocol includes early oral intake and deambulation and multimodal analgesia
Standard care
Oral intake and early deambulation begins 24h after surgery and analgesia consists in only intravenous drugs
Standard care
Oral intake and deambulation 24h after surgery and only intravenous analgesia.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ERAS protocol
ERAS protocol includes early oral intake and deambulation and multimodal analgesia
Standard care
Oral intake and deambulation 24h after surgery and only intravenous analgesia.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* BMI \>35 Kg/m2 with obesity-associated comorbidities
Exclusion Criteria
* Patients undergoing bariatric revisional surgery
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospital General Universitario Elche
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Jaime Ruiz-Tovar, MD, PhD
Research Department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Manuel Duran
Role: STUDY_CHAIR
Hospital Rey Juan carlos
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
General Hospital Elche
Elche, Alicante, Spain
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HRJC17/18
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.